Johnson & Johnson ordered to pay man $8bn over breast growth US drug firm Johnson & Johnson has been told to pay $8bn (£6.6bn) in punitive damages to a man over claims he was not warned that an antipsychotic drug could lead to breast growth.
A Philadelphia jury made the award to Nicholas Murray, 26, whose case was one of thousands pending in the state.
His lawyers argued that J&J subsidiary Janssen put "profits over patients" in marketing the drug Risperdal. BBC News
No comments:
Post a Comment